Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy.

Stanton, Christopher

Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. [electronic resource] - International journal of cardiology Aug 2008 - 38-41 p. digital

Publication Type: Journal Article; Review

1874-1754

10.1016/j.ijcard.2007.05.016 doi


Cardiomyopathy, Dilated--drug therapy
Glucocorticoids--therapeutic use
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Inflammation--physiopathology
Logistic Models
Randomized Controlled Trials as Topic
Statistics, Nonparametric
Stroke Volume